Top Markets
Coin of the day
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Classement en actions #6654
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Prix de l'action
$6.02
Dernière synchronisation: 2026-08-27
Capitalisation boursière
$1.93B
Changement (1 jour)
0.00%
Changement (1 an)
112.72%
Pays
US
Échange Taysha Gene Therapies, Inc. (TSHA)

Catégorie

Historique du prix de l'action pour Taysha Gene Therapies, Inc. (TSHA)
Prix de clôture le plus élevé : $6.22 le 2026-08-01

Prix de clôture le plus bas : $23.52 le 2020-09-01
Historique du prix de l'action de Taysha Gene Therapies, Inc. de 2020 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -5.89%
2025 151.61%
2024 28.42%
2023 -21.84%
2022 -83.88%
2021 -42.11%
2020 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$548.36 39.87%
US
$1.06K 50.29%
NL
$122.42 -11.85%
AU
$140.81 475.44%
US
$765.25 7.74%
CH